Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology.
Title | Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | van Beek, N., Krüger S., Fuhrmann T., Lemcke S., Goletz S., Probst C., Komorowski L., Di Zenzo G., Dmochowski M., Drenovska K., Horn M., Jedlickova H., Kowalewski C., Medenica L., Murrell D., Patsatsi A., Geller S., Uzun S., Vassileva S., Zhu X., Fechner K., Zillikens D., Stöcker W., Schmidt E., & Rentzsch K. |
Journal | J Am Acad Dermatol |
Volume | 83 |
Issue | 5 |
Pagination | 1315-1322 |
Date Published | 2020 Nov |
ISSN | 1097-6787 |
Abstract | BACKGROUND: The current standard in the serologic diagnosis of autoimmune bullous diseases (AIBD) is a multistep procedure sequentially applying different assays. In contrast, the BIOCHIP Mosaic technology combines multiple substrates for parallel analysis by indirect immunofluorescence. |
DOI | 10.1016/j.jaad.2020.01.049 |
Alternate Journal | J Am Acad Dermatol |
PubMed ID | 32004645 |